Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in COVID-19 Patients
NCT04425707Unknown
- Sponsor
- Ministry of Health and Population
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ivermectin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Ministry of Health and Population. Primary endpoint: Role of Ivermectin as a line of treatment for COVID 19 at 2 months. Status: unknown.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04425707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04425707.